Profile Details

Create Project

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire Dr. Nidhi B.

United States

Profile Summary

Goal-oriented research professional currently involved in discovering novel strategies for targeting cancer metastases. More than ten years of experience in gene expression, chromatin remodeling, cancer biology and network analysis, I have steered and successfully completed multi-collaboration projects and developed good interpersonal skills. Several years of collaborative research, extensive publication in peer-reviewed journals, writing grants, analysis and presentation of complex datasets and reviewing scientific literature have honed my skills to effectively communicate science both verbally and in writing.

Subject Matter Expertise

• ☆ Molecular Biology
• ☆ Chromatin
• ☆ Medicine
• ☆ Oncology
• ☆ Cancer Research
• ☆ Grant Writing

Services

• Writing
• Consulting
• Product Development

Work Experience

Postdoctoral fellowship

Icahn School of Medicine at Mount Sinai

February 2013 - July 2016

Postdoctoral fellowship

Wake Forest School of Medicine

January 2011 - January 2013

Education

Ph.D.in Biomedical Sciences

Dr. BR Ambedkar Center for Biomedical Research, University of Delhi

January 2005 - January 2012

Masters in Biomedical Sciences

Dr. BR Ambedkar Center for Biomedical Research, University of Delhi

January 2003 - January 2005

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Bansal, N., Bosch, A., Leibovitch, B., Pereira, L., Cubedo, E., Yu, J., Pierzchalski, K., Jones, J.W., Fishel, M., Kane, M., et al.(2016). Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer . Oncotarget. 7. (28). p. 43689-43702.

Kwon, Y.-J., Petrie, K., Leibovitch, B.A., Zeng, L., Mezei, M., Howell, L., Gil, V., Christova, R., Bansal, N., Yang, S., et al.(2015). Selective inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple-negative breast cancer . Molecular Cancer Therapeutics. 14. (8). p. 1824-1836.

Kadamb, R., Mittal, S., Bansal, N., Saluja, D.(2015). Stress-mediated Sin3B activation leads to negative regulation of subset of p53 target genes . Bioscience Reports. 35. (4).

Bansal, N., Petrie, K., Christova, R., Chung, C.-Y., Leibovitch, B.A., Howell, L., Gil, V., Sbirkov, Y., Lee, E., Wexler, J., et al.(2015). Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer . Oncotarget. 6. (33). p. 34087-34105.

Bansal, N., Mims, J., Kuremsky, J.G., Olex, A.L., Zhao, W., Yin, L., Wani, R., Qian, J., Center, B., Marrs, G.S., et al.(2014). Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer . Antioxidants and Redox Signaling. 21. (2). p. 221-236.

Reisz, J.A., Bansal, N., Qian, J., Zhao, W., Furdui, C.M.(2014). Effects of ionizing radiation on biological molecules - mechanisms of damage and emerging methods of detection . Antioxidants and Redox Signaling. 21. (2). p. 260-292.

Kadamb, R., Mittal, S., Bansal, N., Batra, H., Saluja, D.(2013). Sin3: Insight into its transcription regulatory functions . European Journal of Cell Biology. 92. (8-9). p. 237-246.

Bansal, N., Kadamb, R., Mittal, S., Vig, L., Sharma, R., Dwarakanath, B.S., Saluja, D.(2011). Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress . PLoS ONE. 6. (10).

Kwon YJ, Leibovitch BA, Bansal N, Pereira L, Chung CY, Ariztia EV, Zelent A, Farias EF, Waxman S, Oncotarget, 2016, 2016 .

BOOK

Bansal, N., David, G., Farias, E., Waxman, S.(2016). Emerging Roles of Epigenetic Regulator Sin3 in Cancer . Advances in Cancer Research. 130. p. 113-135.